Williams has spoken about the medication before, explaining that she gained weight after giving birth to her two daughters Alexis Olympia in 2017 and Adira River in 2023 as well as with the onset of menopause
Our view: Oral GLP-1 supplementation, combined with good nutrition and consistent habits, is the more evidence-supported non-prescription option
See FDA News Release: FDA Launches Crackdown on Deceptive Drug Advertising (September 9, 2025)
Reviews focusing on semaglutide specifically [65] and broader examinations of GLP-1 RA mechanisms and clinical data have consistently concluded that these agents represent important therapeutic advances
Go to the Emergency Room for These Symptoms In some cases, symptoms can signal a severe allergic reaction requiring immediate attention
Phase 2 Trial Results (NEJM 2023) The landmark Phase 2 trial enrolled 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27) but without diabetes